AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 72 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $108,225 | -14.8% | 240,500 | 0.0% | 0.04% | -18.6% |
| Q3 2022 | $127,000 | +5.0% | 240,500 | 0.0% | 0.04% | +10.3% |
| Q2 2022 | $121,000 | -78.1% | 240,500 | 0.0% | 0.04% | -75.2% |
| Q1 2022 | $553,000 | -51.6% | 240,500 | 0.0% | 0.16% | -43.3% |
| Q4 2021 | $1,142,000 | -40.3% | 240,500 | 0.0% | 0.28% | -36.2% |
| Q3 2021 | $1,912,000 | +14.4% | 240,500 | 0.0% | 0.43% | -16.1% |
| Q2 2021 | $1,671,000 | -11.8% | 240,500 | 0.0% | 0.52% | -20.9% |
| Q1 2021 | $1,895,000 | +0.1% | 240,500 | 0.0% | 0.65% | +0.9% |
| Q4 2020 | $1,893,000 | +11.2% | 240,500 | 0.0% | 0.65% | +78.0% |
| Q3 2020 | $1,703,000 | -23.3% | 240,500 | 0.0% | 0.36% | -41.4% |
| Q2 2020 | $2,221,000 | +101.2% | 240,500 | 0.0% | 0.62% | -15.3% |
| Q1 2020 | $1,104,000 | -39.8% | 240,500 | 0.0% | 0.73% | -17.4% |
| Q4 2019 | $1,835,000 | -0.8% | 240,500 | 0.0% | 0.89% | -24.1% |
| Q3 2019 | $1,849,000 | +12.9% | 240,500 | 0.0% | 1.17% | +86.1% |
| Q2 2019 | $1,638,000 | -15.3% | 240,500 | 0.0% | 0.63% | -63.7% |
| Q1 2019 | $1,934,000 | – | 240,500 | – | 1.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 340,679 | $3,604,000 | 1.39% |
| Nantahala Capital Management | 2,213,052 | $23,414,000 | 0.95% |
| SCP Investment, LP | 156,137 | $1,652,000 | 0.82% |
| SPHERA FUNDS MANAGEMENT LTD. | 509,118 | $5,386,000 | 0.74% |
| DELTEC ASSET MANAGEMENT LLC | 151,781 | $1,606,000 | 0.32% |
| Rock Springs Capital Management LP | 650,000 | $6,877,000 | 0.26% |
| Orbimed Advisors | 1,865,524 | $19,737,000 | 0.24% |
| Baker Brothers Advisors | 1,387,872 | $14,684,000 | 0.11% |
| EAM Investors, LLC | 56,726 | $600,000 | 0.10% |
| Stanley-Laman Group, Ltd. | 35,036 | $371,000 | 0.08% |